Local sources say the market linked to the cases sold some live animals and animal organs, raising concerns about zoonotic virus spread.
Resources & Literature
Recent Literature
Abelenda-Alonso G, Rombauts A, Gudiol C, et al. Influenza and bacterial coinfection in adults with community-acquired pneumonia admitted to conventional wards: risk factors, clinical features, and outcomes. Open Forum Infect Dis 2020 Mar;7(3)
Aguilar PGR, Arenas VA, Gudino NAV, et al. The impact of tooth brushing versus tooth brushing and chlorhexidine application to avoid postoperative pneumonia in children. Am J Infect Control 2019 (published online Jul 16)
Ahmed SS, Pondo T, Xing W, e al. Early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions—United States. Clin Infect Dis 2019 (published online Aug 12)
Albin OR, Henig O, Patel TS, et al. Clinical implications of microbiologic treatment failure in the setting of clinical cure of bacterial pneumonia. Clin Infect Dis 2019 (published online Dec 13)
Amin-Chowdhury Z, Collins S, Sheppard C, et al. Characteristics of invasive pneumococcal disease (IPD) caused by emerging serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in England: prospective observational cohort study, 2014-18. Clin Infect Dis 2020 (published online Jan 19)
Aris P, Robatjazi S, Nikkhahi F, et al. Molecular mechanisms and prevalence of colistin resistance of Klebsiella pneumoniae in the Middle East region: a review over five last years. J Glob Antimicrob Resist 2020 (published online Jun 23)
Baxter R, Aukes L, Pelton SI, et al. Impact of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease after introduction into routine pediatric use. J Pediatr Infect Dis Soc 2020 (published online May 16)
Benulic K, Pirs M, Couto N, et al. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates. PLoS One 2020 (published online Apr 13)
Bosco E, Zullo AR, McConeghy KW, et al. Geographic variation in pneumonia and influenza in long-term care facilities: a national study. Clin Infect Dis 2020 (published online Jan 29)
Butters C, Phuong LK, Cole T, et al. Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review. JAMA Pediatr 2019 (published online Sep 30)
Cao T, Liu Y, Li Y, et al. A public health concern: emergence of carbapenem-resistant Klebsiella pneumoniae in a public transportation environment. J Antimicrob Chemother 2020 (published online Jul 4)
Castro-Rodriguez JA, Abarca K, Forno E, et al. Asthma and the risk of invasive pneumococcal disease: a meta-analysis. Pediatrics 2019 (published online Dec 16)
Chan T, Tay MZ, Kyaw WM, et al. Epidemiology, vaccine effectiveness, and risk factors for mortality for pneumococcal disease among hospitalised adults in Singapore: a case-control study. BMC Infect Dis 2020 Jun 17;20 (423)
Danis K, Varon E, Lepoutre A, et al. Factors associated with severe non-meningitis invasive pneumococcal disease in adults in France. Open Forum Infect Dis 2019 (published online Nov 30)
Davey RT Jr, Fernandez-Cruz E, Markowitz N, et al. Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial. Lancet Respir Med 2019 (published online Sep 30)
de C Brandileone MC, Zanella RC, Almeida SCG, et al. Long-term effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae in children in Brazil. Vaccine 2019 (published online Jul 24)
De Oliveira LH, Shioda K, Valenzuela MT, et al. Declines in pneumonia mortality following the introduction of pneumococcal conjugate vaccines in Latin American and Caribbean countries. Clin Infect Dis 2020 (published online May 25)
Dernoncourt A, El Samad Y, Schmidt J, et al. Case studies and literature review of pneumococcal septic arthritis in adults. Emerg Infect Dis 2019 (published online Sep 12)
Do Carmo TA, Ferreira IBB, de Menezes RC, et al. Derivation and validation of a novel severity scoring system for pneumonia at ICU admission. Clin Infect Dis 2020 (published online Mar 8)
Eekholm S, Ahlstrom G, Kristensson J, et al. Gaps between current clinical practice and evidence-based guidelines for treatment and care of older patients with community acquired pneumonia: a descriptive cross-sectional study. BMC Infect Dis 2020 Jan 23;20:73
Ernst CM, Braxton JR, Rodriguez-Osorio CA, et al. Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae. Nature Med 2020 (published online Apr 13)
Faingelernt Y, Dagan R, Givon-Lavi N, et al. Nasopharyngeal carriage of invasive pneumococcal serotypes during childhood community-acquired alveolar pneumonia is associated with specific clinical presentation. J Infect Dis 2019 (published online Oct 5)
Fernandez LA, Seco JP, Cebey-Lopez M, et al. Differences between diabetic and non-diabetic patients with community-acquired pneumonia in primary care in Spain. BMC Infect Dis 2019 Nov 15;19:973
